RPS6KB1 and diffuse large B-cell lymphoma: In order to investigate the extent to which the mTOR pathway is activated in AR-DLBCL, we evaluated the expression of p70S6K with two antibodies directed against the combined epitopes against Ser235/236 and Ser240/244 in 128 patients with AR-DLBCL.